Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 101

1.

[Hopes of high dose-rate radiotherapy].

Fouillade C, Favaudon V, Vozenin MC, Romeo PH, Bourhis J, Verrelle P, Devauchelle P, Patriarca A, Heinrich S, Mazal A, Dutreix M.

Bull Cancer. 2017 Apr;104(4):380-384. doi: 10.1016/j.bulcan.2017.01.012. Epub 2017 Mar 7. Review. French.

PMID:
28283183
2.

SETMAR isoforms in glioblastoma: A matter of protein stability.

Dussaussois-Montagne A, Jaillet J, Babin L, Verrelle P, Karayan-Tapon L, Renault S, Rousselot-Denis C, Zemmoura I, Augé-Gouillou C.

Oncotarget. 2017 Feb 7;8(6):9835-9848. doi: 10.18632/oncotarget.14218.

3.

A phase II open-label multicenter study of gefitinib in combination with irradiation followed by chemotherapy in patients with inoperable stage III non-small cell lung cancer.

Levy A, Bardet E, Lacas B, Pignon JP, Adam J, Lacroix L, Artignan X, Verrelle P, Le Péchoux C.

Oncotarget. 2017 Feb 28;8(9):15924-15933. doi: 10.18632/oncotarget.12741.

4.

Role of STAT3 in Genesis and Progression of Human Malignant Gliomas.

Ouédraogo ZG, Biau J, Kemeny JL, Morel L, Verrelle P, Chautard E.

Mol Neurobiol. 2016 Sep 22. [Epub ahead of print] Review.

PMID:
27660268
5.

Global Conservation of Protein Status between Cell Lines and Xenografts.

Biau J, Chautard E, Court F, Pereira B, Verrelle P, Devun F, De Koning L, Dutreix M.

Transl Oncol. 2016 Aug;9(4):313-21. doi: 10.1016/j.tranon.2016.05.005.

6.

Different dose rate-dependent responses of human melanoma cells and fibroblasts to low dose fast neutrons.

Dionet C, Müller-Barthélémy M, Marceau G, Denis JM, Averbeck D, Gueulette J, Sapin V, Pereira B, Tchirkov A, Chautard E, Verrelle P.

Int J Radiat Biol. 2016 Sep;92(9):527-35. doi: 10.1080/09553002.2016.1186300. Epub 2016 Jun 3.

PMID:
27258624
7.

Fractionated stereotactic radiotherapy of benign skull-base tumors: a dosimetric comparison of volumetric modulated arc therapy with Rapidarc® versus non-coplanar dynamic arcs.

Martin F, Magnier F, Berger L, Miroir J, Chautard E, Verrelle P, Lapeyre M, Biau J.

Radiat Oncol. 2016 Apr 18;11:58. doi: 10.1186/s13014-016-0632-8.

8.

[Dbait: An innovative concept to inhibit DNA repair and treat cancer].

Biau J, Devun F, Verrelle P, Dutreix M.

Bull Cancer. 2016 Mar;103(3):227-35. doi: 10.1016/j.bulcan.2016.01.007. Epub 2016 Feb 22. Review. French.

PMID:
26917468
9.

Influence of Nucleoshuttling of the ATM Protein in the Healthy Tissues Response to Radiation Therapy: Toward a Molecular Classification of Human Radiosensitivity.

COPERNIC project investigators, Granzotto A, Benadjaoud MA, Vogin G, Devic C, Ferlazzo ML, Bodgi L, Pereira S, Sonzogni L, Forcheron F, Viau M, Etaix A, Malek K, Mengue-Bindjeme L, Escoffier C, Rouvet I, Zabot MT, Joubert A, Vincent A, Dalla Venezia N, Bourguignon M, Canat EP, d'Hombres A, Thébaud E, Orbach D, Stoppa-Lyonnet D, Radji A, Doré E, Pointreau Y, Bourgier C, Leblond P, Defachelles AS, Lervat C, Guey S, Feuvret L, Gilsoul F, Berger C, Moncharmont C, de Laroche G, Moreau-Claeys MV, Chavaudra N, Combemale P, Biston MC, Malet C, Martel-Lafay I, Laude C, Hau-Desbat NH, Ziouéche A, Tanguy R, Sunyach MP, Racadot S, Pommier P, Claude L, Baleydier F, Fleury B, de Crevoisier R, Simon JM, Verrelle P, Peiffert D, Belkacemi Y, Bourhis J, Lartigau E, Carrie C, De Vathaire F, Eschwege F, Puisieux A, Lagrange JL, Balosso J, Foray N.

Int J Radiat Oncol Biol Phys. 2016 Mar 1;94(3):450-60. doi: 10.1016/j.ijrobp.2015.11.013. Epub 2015 Nov 14.

PMID:
26867874
10.

Combined treatment modalities in Pancoast tumor: results of a monocentric retrospective study.

Jeannin G, Merle P, Janicot H, Thibonnier L, Kwiatkowski F, Naame A, Chadeyras JB, Galvaing G, Belliere A, Filaire M, Verrelle P.

Chin Clin Oncol. 2015 Dec;4(4):39. doi: 10.3978/j.issn.2304-3865.2015.12.01.

11.

The tumoral A genotype of the MGMT rs34180180 single-nucleotide polymorphism in aggressive gliomas is associated with shorter patients' survival.

Fogli A, Chautard E, Vaurs-Barrière C, Pereira B, Müller-Barthélémy M, Court F, Biau J, Pinto AA, Kémény JL, Khalil T, Karayan-Tapon L, Verrelle P, Costa BM, Arnaud P.

Carcinogenesis. 2016 Feb;37(2):169-176. doi: 10.1093/carcin/bgv251. Epub 2015 Dec 30.

PMID:
26717998
12.

Induction or consolidation chemotherapy for unresectable stage III non-small-cell lung cancer patients treated with concurrent chemoradiation: a randomised phase II trial GFPC - IFCT 02-01.

Fournel P, Vergnenégre A, Robinet G, Léna H, Gervais R, Le Caer H, Souquet PJ, Chavaillon JM, Bozonnat MC, Daurès JP, Chouaid C, Martel-Lafay I; GFPC and IFCT Team.

Eur J Cancer. 2016 Jan;52:181-7. doi: 10.1016/j.ejca.2015.10.072. Epub 2015 Dec 12.

PMID:
26689864
13.

Highly efficient radiosensitization of human glioblastoma and lung cancer cells by a G-quadruplex DNA binding compound.

Merle P, Gueugneau M, Teulade-Fichou MP, Müller-Barthélémy M, Amiard S, Chautard E, Guetta C, Dedieu V, Communal Y, Mergny JL, Gallego M, White C, Verrelle P, Tchirkov A.

Sci Rep. 2015 Nov 6;5:16255. doi: 10.1038/srep16255.

14.

Fractionated radiotherapy and radiosurgery of intracranial meningiomas.

Biau J, Khalil T, Verrelle P, Lemaire JJ.

Neurochirurgie. 2015 Jun 19. pii: S0028-3770(14)00283-5. doi: 10.1016/j.neuchi.2014.10.112. [Epub ahead of print] Review.

PMID:
26100035
15.

STAT3 Serine 727 Phosphorylation: A Relevant Target to Radiosensitize Human Glioblastoma.

Ouédraogo ZG, Müller-Barthélémy M, Kemeny JL, Dedieu V, Biau J, Khalil T, Raoelfils LI, Granzotto A, Pereira B, Beaudoin C, Guissou IP, Berger M, Morel L, Chautard E, Verrelle P.

Brain Pathol. 2016 Jan;26(1):18-30. doi: 10.1111/bpa.12254. Epub 2015 Apr 30.

PMID:
25736961
16.

[Elderly patients with glioblastoma: state of the art].

Biau J, Dalloz P, Durando X, Hager MO, Ouédraogo ZG, Khalil T, Lemaire JJ, Chautard E, Verrelle P.

Bull Cancer. 2015 Mar;102(3):277-86. doi: 10.1016/j.bulcan.2015.02.002. Epub 2015 Feb 27. Review. French.

PMID:
25732048
17.

[Whole brain radiation therapy for brain metastases: Advantages and controversies].

Noël G, Tallet A, Truc G, Bernier V, Feuvret L, Assouline A, Antoni D, Verrelle P, Mazeron JJ, Mornex F, Dhermain F.

Cancer Radiother. 2015 Feb;19(1):30-5. doi: 10.1016/j.canrad.2014.12.004. Epub 2015 Feb 7. French.

PMID:
25662599
18.

A preclinical study combining the DNA repair inhibitor Dbait with radiotherapy for the treatment of melanoma.

Biau J, Devun F, Jdey W, Kotula E, Quanz M, Chautard E, Sayarath M, Sun JS, Verrelle P, Dutreix M.

Neoplasia. 2014 Oct 23;16(10):835-44. doi: 10.1016/j.neo.2014.08.008. eCollection 2014 Oct.

19.

Assessment of the risk factors for impending fractures following radiotherapy for long bone metastases using CT scan-based virtual simulation: a retrospective study.

Tatar Z, Soubrier M, Dillies AF, Verrelle P, Boisgard S, Lapeyre M.

Radiat Oncol. 2014 Oct 16;9:227. doi: 10.1186/s13014-014-0227-1.

20.

The chronic lymphocytic leukemia clone disrupts the bone marrow microenvironment.

Janel A, Dubois-Galopin F, Bourgne C, Berger J, Tarte K, Boiret-Dupré N, Boisgard S, Verrelle P, Déchelotte P, Tournilhac O, Berger MG.

Stem Cells Dev. 2014 Dec 15;23(24):2972-82. doi: 10.1089/scd.2014.0229.

PMID:
25055118

Supplemental Content

Loading ...
Support Center